JP2017037014A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017037014A5 JP2017037014A5 JP2015158726A JP2015158726A JP2017037014A5 JP 2017037014 A5 JP2017037014 A5 JP 2017037014A5 JP 2015158726 A JP2015158726 A JP 2015158726A JP 2015158726 A JP2015158726 A JP 2015158726A JP 2017037014 A5 JP2017037014 A5 JP 2017037014A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- sequence consisting
- metal
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 25
- 239000002184 metal Substances 0.000 claims 8
- 229910052751 metal Inorganic materials 0.000 claims 8
- 102000014914 Carrier Proteins Human genes 0.000 claims 6
- 108091008324 binding proteins Proteins 0.000 claims 6
- 239000011230 binding agent Substances 0.000 claims 5
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 3
- 238000005259 measurement Methods 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 102000004316 Oxidoreductases Human genes 0.000 claims 1
- 108090000854 Oxidoreductases Proteins 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 238000000691 measurement method Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
Claims (10)
(a)以下の(1)〜(17)の何れかに記載のアミノ酸配列;
(1)K、K、R、E、V及びRからなるアミノ酸配列、
(2)V、Y、N、K、R及びKからなるアミノ酸配列、
(3)S、R、A、A、K及びYからなるアミノ酸配列、
(4)Q、K、R、K、V及びVからなるアミノ酸配列、
(5)K、G、R、G、R及びVからなるアミノ酸配列、
(6)K、R、K、A、A及びMからなるアミノ酸配列、
(7)K、T、R、G、V及びKからなるアミノ酸配列、
(8)K、Q、K、K、T及びTからなるアミノ酸配列、
(9)R、T、R、N、R及びSからなるアミノ酸配列、
(10)T、Q、K、G、R及びKからなるアミノ酸配列、
(11)K、G、A、K、K及びVからなるアミノ酸配列、
(12)K、K、T、S、K及びGからなるアミノ酸配列、
(13)K、T、R、M、R及びGからなるアミノ酸配列、
(14)L、K、D、K、K及びKからなるアミノ酸配列、
(15)R、G、Y、K、K及びGからなるアミノ酸配列、
(16)R、K、G、N、K及びAからなるアミノ酸配列、
(17)R、V、G、R、K及びGからなるアミノ酸配列
(b)(a)に記載のアミノ酸配列において1又は数個のアミノ酸が欠失、置換もしくは付加されたアミノ酸配列。 A binding agent comprising a peptide having the following amino acid sequence (a) or (b) and having a binding ability to a metal:
(A) the amino acid sequence according to any one of (1) to (17) below:
(1) an amino acid sequence consisting of K, K, R, E, V and R;
(2) an amino acid sequence consisting of V, Y, N, K, R and K;
(3) an amino acid sequence consisting of S, R, A, A, K and Y,
(4) an amino acid sequence consisting of Q, K, R, K, V and V;
(5) an amino acid sequence consisting of K, G, R, G, R and V;
(6) an amino acid sequence consisting of K, R, K, A, A and M;
(7) an amino acid sequence consisting of K, T, R, G, V and K;
(8) an amino acid sequence consisting of K, Q, K, K, T and T;
(9) an amino acid sequence consisting of R, T, R, N, R and S,
(10) an amino acid sequence consisting of T, Q, K, G, R and K;
(11) an amino acid sequence consisting of K, G, A, K, K and V,
(12) an amino acid sequence consisting of K, K, T, S, K and G;
(13) an amino acid sequence consisting of K, T, R, M, R and G;
(14) an amino acid sequence consisting of L, K, D, K, K and K;
(15) an amino acid sequence consisting of R, G, Y, K, K and G;
(16) an amino acid sequence consisting of R, K, G, N, K and A,
(17) Amino acid sequence consisting of R, V, G, R, K, and G, wherein one or several amino acids are deleted, substituted, or added in the amino acid sequence described in (b) (a).
(c)配列番号1〜17の何れかに記載のアミノ酸配列;
(d)(c)に記載のアミノ酸配列の逆配列;
(e)(c)又は(d)に記載のアミノ酸配列において1又は数個のアミノ酸が欠失、置換もしくは付加されたアミノ酸配列。 The binding agent according to claim 1, comprising a peptide having the following amino acid sequence (c), (d) or (e) and having a binding ability to a metal:
(C) the amino acid sequence according to any one of SEQ ID NOs: 1 to 17;
(D) a reverse sequence of the amino acid sequence described in (c);
(E) An amino acid sequence in which one or several amino acids are deleted, substituted or added in the amino acid sequence described in (c) or (d).
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015158726A JP6623406B2 (en) | 2015-08-11 | 2015-08-11 | Binder |
| PCT/JP2016/073537 WO2017026505A1 (en) | 2015-08-11 | 2016-08-10 | Binding agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015158726A JP6623406B2 (en) | 2015-08-11 | 2015-08-11 | Binder |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017037014A JP2017037014A (en) | 2017-02-16 |
| JP2017037014A5 true JP2017037014A5 (en) | 2018-10-04 |
| JP6623406B2 JP6623406B2 (en) | 2019-12-25 |
Family
ID=58047297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015158726A Active JP6623406B2 (en) | 2015-08-11 | 2015-08-11 | Binder |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6623406B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101970327B1 (en) * | 2017-04-13 | 2019-04-18 | 고려대학교 산학협력단 | A Method for Accurate, Rapid, and Convenient One-Step-Diagnosis of Disease Based on Signal Self-Enhancement |
| JPWO2024024517A1 (en) | 2022-07-26 | 2024-02-01 | ||
| JPWO2024024518A1 (en) | 2022-07-26 | 2024-02-01 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060246426A1 (en) * | 2003-09-26 | 2006-11-02 | Biohesion, Inc. | Recombinant fusion proteins with high affinity binding to gold and applications thereof |
| CA2785376A1 (en) * | 2009-11-20 | 2011-05-26 | Tokyo Metropolitan Institute Of Medical Science | Pharmaceutical composition |
| WO2013143026A1 (en) * | 2012-03-31 | 2013-10-03 | Abmart (Shanghai) Co., Ltd | Peptide and antibody libraries and uses thereof |
| JP2014205626A (en) * | 2013-04-11 | 2014-10-30 | 学校法人東京薬科大学 | Platinum binder, and use thereof |
-
2015
- 2015-08-11 JP JP2015158726A patent/JP6623406B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015212284A5 (en) | ||
| JP2016505138A5 (en) | ||
| CN110214154A (en) | Anti-CD47 antibody and use thereof | |
| JP2015519344A5 (en) | ||
| JP2016519932A5 (en) | ||
| HRP20220214T1 (en) | Immunomodulatory agents | |
| JP2014224126A5 (en) | ||
| JP2015134758A5 (en) | ||
| WO2011063003A3 (en) | Peptides and methods for the detection of lyme disease antibodies | |
| JP2017536846A5 (en) | ||
| CY1114747T1 (en) | CHEMISTRY OF PHAGE POLYMERIZATION DNA Φ 29 | |
| JP2018531624A5 (en) | ||
| JP2016512214A5 (en) | ||
| JP2014526881A5 (en) | ||
| HK1215441A1 (en) | Human serum albumin binding compounds and fusion proteins thereof | |
| JP2016537981A5 (en) | ||
| CN109937252A (en) | recombinant DNA polymerase | |
| JP2015524403A5 (en) | ||
| JP2019535321A5 (en) | ||
| WO2015112558A3 (en) | Peptides, devices, and methods for the detection of anaplasma antibodies | |
| JP2017037014A5 (en) | ||
| EA201790341A1 (en) | ANTI-CK8 ANTIBODIES FOR USE IN TREATMENT OF CANCER | |
| JP2018511344A5 (en) | ||
| RU2015130287A (en) | ADAPTATION OF THE VIRUS INFLUENZA H5 TO MAN | |
| JP2017521086A5 (en) |